"Preclinical" AD revisited: neuropathology of cognitively normal older adults - PubMed (original) (raw)
. 2000 Aug 8;55(3):370-6.
doi: 10.1212/wnl.55.3.370.
Affiliations
- PMID: 10932270
- DOI: 10.1212/wnl.55.3.370
"Preclinical" AD revisited: neuropathology of cognitively normal older adults
F A Schmitt et al. Neurology. 2000.
Abstract
Objective: To classify neuropathologic alterations in the brains of nondemented older adults using current sets of criteria for AD.
Background: AD neuropathologic alterations are found in the brains of some nondemented elderly subjects and suggest the possibility of presymptomatic AD. Three sets of guidelines have been developed to classify AD using senile plaques, neuritic plaques, and neurofibrillary tangles (NFT).
Methods: Neuropathologic changes in 59 older adults followed longitudinally with a standard battery of mental status measures were investigated using Khachaturian, Consortium to Establish a Registry for Alzheimer's Disease (CERAD), and National Institute on Aging-Reagan Institute (NIA-RI) guidelines. AD neuropathologic markers were evaluated in neocortical and allocortical regions. Cases were categorized as neuropathologically "normal" or "AD-like" and compared for possible mental status differences.
Results: Between 11 and 49% of cases met one or more of the three classifications of AD. With adjustments for multiple comparisons, only NFT in hippocampal CA1 region were associated with autopsy age, suggesting that this may represent a pathologic process associated with normal brain aging. Using the NIA-RI guidelines, subjects in the AD-like group performed less well on the immediate paragraph recall and word-list delayed recall than their counterparts who did not meet these guidelines.
Conclusions: These data indicate that the prevalence of "preclinical" AD in our population is relatively low based on the NIA-RI classification. Although many subjects had AD-like changes based on CERAD and Khachaturian guidelines, they exhibited no differences in mental performance, suggesting that the aging brain may be able to withstand such structural changes without meaningful impact on mental functioning.
Similar articles
- Neuropathology of cognitively normal elderly.
Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H, Petersen RC. Knopman DS, et al. J Neuropathol Exp Neurol. 2003 Nov;62(11):1087-95. doi: 10.1093/jnen/62.11.1087. J Neuropathol Exp Neurol. 2003. PMID: 14656067 - Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Newell KL, et al. J Neuropathol Exp Neurol. 1999 Nov;58(11):1147-55. doi: 10.1097/00005072-199911000-00004. J Neuropathol Exp Neurol. 1999. PMID: 10560657 - Alzheimer neuropathologic alterations in aged cognitively normal subjects.
Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Davis DG, et al. J Neuropathol Exp Neurol. 1999 Apr;58(4):376-88. doi: 10.1097/00005072-199904000-00008. J Neuropathol Exp Neurol. 1999. PMID: 10218633 - Neuropathology of Alzheimer's disease: a critical update.
Jellinger KA, Bancher C. Jellinger KA, et al. J Neural Transm Suppl. 1998;54:77-95. doi: 10.1007/978-3-7091-7508-8_8. J Neural Transm Suppl. 1998. PMID: 9850917 Review. - Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer's disease.
Jellinger KA, Bancher C. Jellinger KA, et al. Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S55-65. doi: 10.1016/s0197-4580(97)00071-7. Neurobiol Aging. 1997. PMID: 9330987 Review.
Cited by
- Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample.
Stephan BC, Matthews FE, Ma B, Muniz G, Hunter S, Davis D, McKeith IG, Foster G, Ince PG, Brayne C. Stephan BC, et al. J Alzheimers Dis. 2012;29(2):309-18. doi: 10.3233/JAD-2011-110518. J Alzheimers Dis. 2012. PMID: 22233761 Free PMC article. - Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
Beach TG, Sue LI, Walker DG, Sabbagh MN, Serrano G, Dugger BN, Mariner M, Yantos K, Henry-Watson J, Chiarolanza G, Hidalgo JA, Souders L. Beach TG, et al. J Alzheimers Dis. 2012;28(4):869-76. doi: 10.3233/JAD-2011-111340. J Alzheimers Dis. 2012. PMID: 22112552 Free PMC article. - A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity.
D'Angelo F, Vignaud H, Di Martino J, Salin B, Devin A, Cullin C, Marchal C. D'Angelo F, et al. Dis Model Mech. 2013 Jan;6(1):206-16. doi: 10.1242/dmm.010108. Epub 2012 Aug 10. Dis Model Mech. 2013. PMID: 22888099 Free PMC article. - Amyloid load in nondemented brains correlates with APOE e4.
Caselli RJ, Walker D, Sue L, Sabbagh M, Beach T. Caselli RJ, et al. Neurosci Lett. 2010 Apr 12;473(3):168-71. doi: 10.1016/j.neulet.2010.02.016. Epub 2010 Feb 12. Neurosci Lett. 2010. PMID: 20153809 Free PMC article. - The application of positron-emitting molecular imaging tracers in Alzheimer's disease.
Cohen RM. Cohen RM. Mol Imaging Biol. 2007 Jul-Aug;9(4):204-16. doi: 10.1007/s11307-007-0094-3. Mol Imaging Biol. 2007. PMID: 17354042 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous